Blood Res.  2021 Mar;56(1):46-50. 10.5045/br.2021.2020160.

Acute lymphoblastic leukemia masquerading as acute myelofibrosis: a report of two cases and literature review

• Jain A
• Sharma M
• Khunger JM
• Prasad P
• Gupta DK
• Saluja S
• Chaudhry S

• KMID: 2514065
• DOI: http://doi.org/10.5045/br.2021.2020160

Abstract

No abstract available

Figure

• 

  Fig. 1 Bone marrow biopsy. (A) Extensive fibrosis (WHO grade: 2) with interspersed atypical cells (hematoxylin and eosin, ×10). (B) Reticulin fibrosis (silver stain, ×10).

• 

  Fig. 2 Flow cytometry plots. (A) Precursor B-ALL. Blasts were positive for CD34, CD117, CD38, C20, CD19, CD79a, CD10, and cytoplasmic CD22. Blasts were negative for HLADR, cytoplasmic CD3, CD7, CD5, CD1a, CD2, CD3, CD4, CD8, CD13, CD33, MPO, CD64, and CD10. (B) Early T-precursor ALL. Blasts were positive for CD34, CD117, HLADR, cCD3, CD38, CD123, CD99, and CD7. Blast were negative for CD5, CD1a, CD2, CD3, CD4, CD8, CD13, CD33, MPO, CD64, CD20, CD19, CD79a, and CD56.

Reference

1. Tefferi A. 2018; Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management. Am J Hematol. 93:1551–60. DOI: 10.1002/ajh.25230. PMID: 30039550.

2. Amjad H, Gezer S, Inoue S, et al. 1980; Acute myelofibrosis terminating in an acute lymphoblastic leukemia: a case report. Cancer. 46:615–8. DOI: 10.1002/1097-0142(19800801)46:3<615::AID-CNCR2820460331>3.0.CO;2-X. PMID: 6930986.

3. Chen JS, Lin DT, Chuu WM, Lin KH, Su IJ, Lin KS. 1992; Acute myelofibrosis terminating in acute lymphoblastic leukemia: report of one case. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 33:136–43. PMID: 1514403.

4. Dunphy CH, Kitchen S, Saravia O, Velasquez WS. 1996; Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature. Am J Hematol. 51:85–9. DOI: 10.1002/(SICI)1096-8652(199601)51:1<85::AID-AJH14>3.0.CO;2-A. PMID: 8571944.

5. Abla O, Ye CC. 2006; Acute lymphoblastic leukemia with massive myelofibrosis. J Pediatr Hematol Oncol. 28:633–4. DOI: 10.1097/01.mph.0000212982.44243.80. PMID: 17006275.

6. Avcı Z, Malbora B, Gülşan M, Şahin FI, Celasun B, Özbek N. 2009; Acute massive myelofibrosis with acute lymphoblastic leukemia. Turk J Haematol. 26:204–6. PMID: 27265634.

7. Gonzalez MM, Kidd L, Quesada J, Nguyen N, Chen L. 2013; Acute myelofibrosis and acute lymphoblastic leukemia in an elderly patient with previously treated multiple myeloma. Ann Clin Lab Sci. 43:176–80. PMID: 23694793.

8. Friesenbichler W, Schumich A, Simonitsch-Klupp I, et al. 2018; Concurrent acute myelofibrosis and acute lymphoblastic leukemia in childhood: case report and review of the literature. J Pediatr Hematol Oncol. 40:235–7. DOI: 10.1097/MPH.0000000000000993. PMID: 29557917.

9. Bain BJ, Catovsky D, O'Brien M, et al. 1981; Megakaryoblastic leukemia presenting as acute myelofibrosis -- a study of four cases with the platelet-peroxidase reaction. Blood. 58:206–13. DOI: 10.1182/blood.V58.2.206.206. PMID: 6264993.

10. Verhoef GE, De Wolf-Peeters C, Ferrant A, et al. 1991; Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features. Ann Hematol. 63:235–41. DOI: 10.1007/BF01698371. PMID: 1958747.

11. Norén-Nyström U, Roos G, Bergh A, et al. 2008; Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome. Leukemia. 22:504–10. DOI: 10.1038/sj.leu.2405072. PMID: 18094715.

12. Yokoyama K, Amamiya T, Kawai Y, et al. 1997; Acute lymphocytic leukemia associated with severe myelofibrosis. Keio J Med. 46:196–204. PMID: 9444932.

13. Ray R, Garewal G, Marwaha RK, Marwaha N. 1993; Childhood myelofibrosis: transformation to acute lymphoblastic leukemia. Pediatr Hematol Oncol. 10:175–8. DOI: 10.3109/08880019309016553. PMID: 8093117.

14. Nordan UZ, Humbert JR. 1979; Myelofibrosis and acute lymphoblastic leukemia in a child with Down syndrome. J Pediatr. 94:253–5. DOI: 10.1016/S0022-3476(79)80837-9. PMID: 153954.

15. Marino R, Altshuler G, Humphrey GB. 1979; Idiopathic myelofibrosis followed by acute lymphoblastic leukemia. Am J Dis Child. 133:1194–5. DOI: 10.1001/archpedi.1979.02130110102022. PMID: 292303.

16. Eliacik E, Isik A, Aydin C, et al. 2015; Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia. Hematology. 20:392–6. DOI: 10.1179/1607845414Y.0000000221. PMID: 25517484.